Haemostasis Embolisation
Conditions
Keywords
Emergency, Hemostatic agent, NBCA bleeding, Trans-arterial embolisation
Brief summary
NBCA is a synthetic biodegradable cyanoacrylate basis glue, modified by the addition of a monomer with adhesive, hemostatic, and antiseptic properties. Its use requires a steep learning curve to control emulsification of the NBCA/lipiodol mixture, and injection, to avoid non-target embolization. The aim of this retrospective monocentric study was to evaluate safety and efficacy of use of NBCA as embolic agent in emergency setting.
Interventions
OTHERClinical data
Collecting data from the medical record.
OTHERImaging data
Collecting data from the medical record.
OTHERBiological data
Collecting data from the medical record.
Sponsors
Centre Hospitalier Universitaire de Saint Etienne
Study design
Observational model
COHORT
Time perspective
RETROSPECTIVE
Eligibility
Sex/Gender
ALL
Age
18 Years to No maximum
Inclusion criteria
* All patients referred to our hospital and treated by TAE with NBCA, based on clinical decisions in emergency and CT scan.
Exclusion criteria
* Patients lost for follow-up, patients without preoperative CT.
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Evaluation of technical success | Month : 1 | Analysis of angiographic results. |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| Assessment of clinical success | Month : 1 | Disappearance of signs and symptoms of bleeding during the 30 days of follow-up after WT |
Countries
France
Outcome results
None listed